Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-06-12 @ 5:34 AM
Study NCT ID:
NCT01698905
Status:
COMPLETED
Last Update Posted:
2025-09-02
First Post:
2012-10-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAMN107A2408
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None